GSK Biologicals Interested in Buying BE's Vaccine Unit

by Dr. Trupti Shirole on  April 22, 2011 at 8:21 PM Indian Health News
RSS Email Print This Page Comment bookmark
Font : A-A+

A division of global drug giant Glaxo, GlaxoSmithKline Biologicals based in Belgium is in talks with the Hyderabad-based Biological E Ltd (BE) to purchase its vaccines division.
 GSK Biologicals Interested in Buying BE's Vaccine Unit
GSK Biologicals Interested in Buying BE's Vaccine Unit

This vaccine division produces and markets a range of pediatric and adult vaccines. The Diphtheria and Tetanus vaccine has given the company a sizeable market share in the Indian vaccine market. BE claims to be the first private sector company to enter the vaccines market.

Recently Glaxo's current plant in Nasik faced some constraints in supplying vaccines and therefore it would be interested in buying companies with modern manufacturing facilities approved by international agencies like US FDA. The BE vaccine unit buyout will give GSK Biologicals additional capacity in India.


Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Top 10 Vaccine Myths Debunked 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive